Iovance Biotherapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC IOVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

469,706

Value ($000)

1,282

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,282	0.0%	469,706	12/31/2025
2025 Q3	11/14/2025	1,045	0.0%	481,781	9/30/2025
2025 Q2	8/14/2025	1,130	0.0%	657,209	6/30/2025
2025 Q1	5/19/2025	19,239	0.0%	5,777,344	3/31/2025
2024 Q4	2/14/2025	14,117	0.0%	1,907,727	12/31/2024
2024 Q3	11/14/2024	18,281	0.0%	1,946,842	9/30/2024
2024 Q2	8/14/2024	15,996	0.0%	1,994,500	6/30/2024
2024 Q1	5/15/2024	2,665	0.0%	179,850	3/31/2024
2023 Q4	2/14/2024	1,463	0.0%	179,897	12/31/2023
2023 Q3	11/13/2023	827	0.0%	181,662	9/30/2023
2023 Q2	8/11/2023	783	0.0%	128,171	6/30/2023
2023 Q1	5/15/2023	783	0.0%	128,171	3/31/2023
2022 Q4	2/14/2023	819	0.0%	128,171	12/31/2022
2022 Q3	11/14/2022	1,228	0.0%	128,171	9/30/2022
2022 Q2	8/12/2022	1,731	0.0%	156,807	6/30/2022
2022 Q1	5/16/2022	3,622	0.0%	217,535	3/31/2022
2021 Q4	2/14/2022	3,399	0.0%	178,061	12/31/2021
2021 Q3	11/15/2021	4,296	0.0%	174,227	9/30/2021
2021 Q2	8/16/2021	4,577	0.0%	175,911	6/30/2021
2021 Q1	5/14/2021	9,815	0.0%	309,999	3/31/2021
2020 Q4	3/1/2021	14,411	0.0%	310,588	12/31/2020
2020 Q3	11/13/2020	9,549	0.0%	290,057	9/30/2020
2020 Q2	8/14/2020	7,962	0.0%	290,072	6/30/2020
2020 Q1	5/15/2020	7,878	0.0%	263,155	3/31/2020
2019 Q4	2/14/2020	3,013	0.0%	108,862	12/31/2019